Figure 4
From: Nilotinib treatment outcomes in autosomal dominant spinocerebellar ataxia over one year
Classification of the DEPs according to their expression patterns. Differentially expressed proteins (DEPs) were classified into 5 classes according to their expression pattern. Class 1 exhibits the lowest expression level in the subjects responsive to nilotinib (subgroup R), an intermediate level in the subjects nonresponsive to nilotinib (subgroup N), and the highest expression level in the control subjects (subgroup C). Class 2 exhibits the lowest expression level in subgroup N, an intermediate level in subgroup C, and the highest expression level in subgroup R. Class 3 exhibits the lowest expression level in subgroup C, an intermediate level in subgroup N, and the highest expression level in subgroup R.
